Fingolimod lauryl sulfate

N/A

Report date: 2024/06/07 10:49:09

Base Information

Drug NameFingolimod lauryl sulfate
Drug Alias NameTascenso ODT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 modulatorsSphingosine 1-phosphate receptor 3 modulatorsSphingosine 1-phosphate receptor 4 modulators +[4] 
TargetsSphingosine 1-Phosphate Receptor 1Sphingosine 1-phosphate receptor 3Sphingosine 1-phosphate receptor 4 +[4] 
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-Remitting
Global Approved IndicationsMultiple Sclerosis, Relapsing-Remitting
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/12/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanda Neuroscience LLC
China Registration ClassN/A

Develop Information

Active CompaniesCycle Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis, Relapsing-Remitting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A